Published in Cell Regul on August 01, 1990
Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. J Clin Invest (1993) 1.51
Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice. Proc Natl Acad Sci U S A (1998) 1.26
Natriuretic peptides inhibit angiotensin II-induced proliferation of rat cardiac fibroblasts by blocking endothelin-1 gene expression. J Clin Invest (1995) 1.21
Evidence for a role of endothelin 1 and protein kinase C in nitroglycerin tolerance. Proc Natl Acad Sci U S A (1995) 1.11
Endothelium and its alterations in cardiovascular diseases: life style intervention. Biomed Res Int (2014) 1.03
Atheromas feel the pressure: biomechanical stress and atherosclerosis. Am J Pathol (2010) 0.90
Bosentan-improved cardiopulmonary vascular performance and increased plasma levels of endothelin-1 in porcine endotoxin shock. Br J Pharmacol (1996) 0.89
Role of endothelin-1 in acute lung injury. Transl Res (2009) 0.84
Activation of ETB receptors regulates the abundance of ET-1 mRNA in vascular endothelial cells. Br J Pharmacol (2008) 0.83
Up-regulation of endothelin-1 mRNA and peptide expression in rat cardiac allografts with rejection and arteriosclerosis. Am J Pathol (1995) 0.81
Heterologous in vivo processing of human preproendothelin 1 into bioactive peptides. Proc Natl Acad Sci U S A (1991) 0.80
The role of endothelin-A receptors in cardiovascular responses to acute hypoxaemia in the late gestation sheep fetus. J Physiol (1998) 0.79
Endothelin A receptor antagonists in congestive heart failure: blocking the beast while leaving the beauty untouched? Heart Fail Rev (2001) 0.78
Two preproendothelin 1 mRNAs transcribed by alternative promoters. J Clin Invest (1993) 0.78
Regional variability in preproEndothelin-1 gene expression in sheep pulmonary artery and lung during the onset of air-induced chronic pulmonary hypertension. Participation Of arterial smooth muscle cells. J Clin Invest (1998) 0.77
Pulmonary artery smooth muscle cell endothelin-1 expression modulates the pulmonary vascular response to chronic hypoxia. Am J Physiol Lung Cell Mol Physiol (2014) 0.76
Endothelin and the renal microcirculation. Semin Nephrol (2015) 0.75
A heptameric peptide purified from Spirulina sp. gastrointestinal hydrolysate inhibits angiotensin I-converting enzyme- and angiotensin II-induced vascular dysfunction in human endothelial cells. Int J Mol Med (2017) 0.75
Endothelin in congestive heart failure. Basic Res Cardiol (1996) 0.75
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem (1983) 206.01
Genomic sequencing. Proc Natl Acad Sci U S A (1984) 92.36
A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature (1988) 27.60
Rat insulin genes: construction of plasmids containing the coding sequences. Science (1977) 17.05
The pathogenesis of atherosclerosis--an update. N Engl J Med (1986) 14.59
Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells. Nature (1985) 10.13
Role of endothelium in responses of vascular smooth muscle. Circ Res (1983) 7.03
Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci U S A (1987) 6.43
Early signals in the mitogenic response. Science (1986) 5.89
The smooth muscle cell in culture. Physiol Rev (1979) 5.03
Cloning and sequence analysis of cDNA encoding the precursor of a human endothelium-derived vasoconstrictor peptide, endothelin: identity of human and porcine endothelin. FEBS Lett (1988) 3.96
Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent. Science (1986) 3.34
Replication of smooth muscle cells in vascular disease. Circ Res (1986) 2.98
Modulation of vascular smooth muscle contraction by the endothelium. Annu Rev Physiol (1986) 2.76
Transforming growth factor beta increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability. Proc Natl Acad Sci U S A (1988) 2.73
Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Lett (1988) 2.44
Endothelin stimulates phospholipase C, Na+/H+ exchange, c-fos expression, and mitogenesis in rat mesangial cells. J Clin Invest (1989) 2.17
Circulating and tissue angiotensin systems. J Clin Invest (1987) 2.16
Transforming growth factors and the regulation of cell proliferation. Eur J Biochem (1990) 2.15
Cytoskeleton of rat aortic smooth muscle cells. Normal conditions and experimental intimal thickening. Lab Invest (1984) 2.15
Control of smooth muscle cell growth by components of the extracellular matrix: autocrine role for thrombospondin. Proc Natl Acad Sci U S A (1986) 2.10
Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest (1989) 2.10
Platelet-derived growth factor and heparin-like glycosaminoglycans regulate thrombospondin synthesis and deposition in the matrix by smooth muscle cells. J Cell Biol (1985) 2.05
Molecular biology and biochemistry of the endothelins. Trends Pharmacol Sci (1989) 2.02
Cell surface thrombospondin is functionally essential for vascular smooth muscle cell proliferation. J Cell Biol (1988) 1.94
Expression and developmental control of platelet-derived growth factor A-chain and B-chain/Sis genes in rat aortic smooth muscle cells. Proc Natl Acad Sci U S A (1988) 1.92
A novel vasoactive peptide endothelin stimulates mitogenesis through inositol lipid turnover in Swiss 3T3 fibroblasts. J Biol Chem (1989) 1.92
Transforming growth factor-beta stimulates the expression of endothelin mRNA by vascular endothelial cells. Biochem Biophys Res Commun (1989) 1.88
Transforming growth factor-beta-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells. J Cell Biol (1988) 1.73
What controls smooth muscle phenotype? Atherosclerosis (1982) 1.57
Growth factor control of myoepithelial-cell differentiation in cultures of human mammary gland. Differentiation (1988) 1.47
Growth factor expression in aorta of normotensive and hypertensive rats. J Clin Invest (1989) 1.46
Endothelin 1, an endothelium-derived peptide, is expressed in neurons of the human spinal cord and dorsal root ganglia. Proc Natl Acad Sci U S A (1989) 1.44
Interleukin 1 increases the production of endothelin-1 by cultured endothelial cells. Biochem Biophys Res Commun (1990) 1.35
TGF-beta stimulates primary human skin fibroblast DNA synthesis via an autocrine production of PDGF-related peptides. J Cell Physiol (1989) 1.33
Endothelin-mediated stimulation of DNA synthesis in vascular smooth muscle cells. Biochem Biophys Res Commun (1989) 1.26
Release of different relaxing factors by cultured porcine endothelial cells. Circ Res (1989) 1.24
Induction of growth-related metabolism in human vascular smooth muscle cells by low density lipoprotein. J Biol Chem (1989) 1.23
Secretory mechanism of immunoreactive endothelin in cultured bovine endothelial cells. Biochem Biophys Res Commun (1989) 1.21
Regulation of vascular smooth muscle cell growth by endothelial-synthesized extracellular matrices. Arteriosclerosis (1987) 1.09
Characterization of induction of protooncogene c-myc and cellular growth in human vascular smooth muscle cells by insulin and IGF-I. Diabetes (1989) 1.03
Rat aortic smooth muscle cells in culture express kallikrein, kininogen, and bradykininase activity. J Clin Invest (1990) 1.02
Low density lipoprotein causes general cellular activation with increased phosphatidylinositol turnover and lipoprotein catabolism. Proc Natl Acad Sci U S A (1988) 1.00
Large conduit arteries in hypertension: role of the vascular renin-angiotensin system. Circulation (1988) 0.97
Endothelin messenger RNA and receptors are differentially expressed in cultured human breast epithelial and stromal cells. J Clin Invest (1990) 0.95
Allelic variation in HLA-B and HLA-C sequences and the evolution of the HLA-B alleles. Immunogenetics (1989) 0.89
Mechanisms involved in calcium-mobilizing agonist responses. Adv Cyclic Nucleotide Protein Phosphorylation Res (1986) 0.88
Post-receptor signalling pathways. Lancet (1989) 0.84
Regulation of smooth muscle proliferative phenotype by heparinoid--matrix interactions. Trends Pharmacol Sci (1988) 0.83
Mechanism of insulin action. Nature (1987) 0.82
Calcium as an intracellular mediator of hormone action: intracellular phospholipid signaling systems. Am J Med Sci (1988) 0.82
Causes of chest pain in patients with normal coronary angiograms: the eye of the beholder. Am J Cardiol (1988) 0.80
Endothelin, its diverse biological activities and mechanisms of action. Prog Growth Factor Res (1989) 0.76
Stromal gene signatures in large-B-cell lymphomas. N Engl J Med (2008) 11.34
Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med (2001) 4.83
Essential hypertension: renin and aldosterone, heart attack and stroke. N Engl J Med (1972) 4.80
Protein phosphatase-1 and protein phosphatase-2A from rabbit skeletal muscle. Methods Enzymol (1988) 3.88
Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases. N Engl J Med (1972) 3.73
Spiral Tube Assembly for High-Speed Countercurrent Chromatography: Choice of Elution Modes for Four Typical Two-Phase Solvent Systems. J Liq Chromatogr Relat Technol (2008) 3.33
Fixation of fractures of the shaft of the humerus by dynamic compression plate or intramedullary nail. A prospective, randomised trial. J Bone Joint Surg Br (2000) 2.81
Behavioral engineering: the reduction of smoking behavior by a conditioning apparatus and procedure. J Appl Behav Anal (1968) 2.71
DNA by mail: an inexpensive and noninvasive method for collecting DNA samples from widely dispersed populations. Behav Genet (1997) 2.64
Improved spiral tube assembly for high-speed counter-current chromatography. J Chromatogr A (2008) 2.48
Payment to healthcare professionals for patient recruitment to trials: a systematic review. BMJ (2005) 2.16
Blood pressure control by the renin-angiotensin system in normotensive subjects. Assessment by angiotensin converting enzyme and renin inhibition. Circulation (1992) 2.15
Clinicopathological staging of gastric cancer. Br J Surg (1984) 2.10
Predicting outcome in anaesthesia: understanding statistical methods. Anaesth Intensive Care (1994) 2.03
Behavioral engineering: the use of response priming to improve prescribed self-medication. J Appl Behav Anal (1969) 2.02
Antihypertensive beta blocking action as related to renin and age: a pharmacologic tool to identify pathogenetic mechanisms in essential hypertension. Am J Cardiol (1975) 2.00
Proteome-based plasma biomarkers for Alzheimer's disease. Brain (2006) 1.98
Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension. Circulation (1990) 1.98
The surgical margin in soft-tissue sarcoma. J Bone Joint Surg Am (1989) 1.86
Amino acid sequence of rabbit kidney neutral endopeptidase 24.11 (enkephalinase) deduced from a complementary DNA. EMBO J (1987) 1.82
The catalytic subunits of protein phosphatase-1 and protein phosphatase 2A are distinct gene products. Eur J Biochem (1984) 1.76
Cellular fatty acid composition of organisms frequently associated with human infections resulting from dog bites: Pasteurella multocida and groups of EF-4, IIj, M-5, and DF-2. J Clin Microbiol (1981) 1.72
Glycoprotein, elastin, and collagen secretion by rat smooth muscle cells. Proc Natl Acad Sci U S A (1979) 1.71
Plaque enhancement of enteroviruses by magnesium chloride, cysteine, and pancreatin. J Bacteriol (1966) 1.70
Decreased Beta-adrenoreceptor responsiveness as related to age, blood pressure, and plasma catecholamines in patients with essential hypertension. Hypertension (1980) 1.69
Differential protease, innate immunity, and NF-kappaB induction profiles during lung inflammation induced by subchronic cigarette smoke exposure in mice. Am J Physiol Lung Cell Mol Physiol (2005) 1.66
Antigen- and receptor-driven regulatory mechanisms. I. Induction of suppressor T cells with anti-idiotypic antibodies. J Exp Med (1979) 1.62
Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N Engl J Med (1986) 1.60
Unilateral laterothoracic exanthem. A clinicopathologic study of forty-eight patients. J Am Acad Dermatol (1996) 1.60
Characterisation of a reconstituted Mg-ATP-dependent protein phosphatase. Eur J Biochem (1983) 1.58
A common polymorphism in the methylenetetrahydrofolate reductase gene, homocysteine, and ischemic cerebrovascular disease. Stroke (1997) 1.58
Suppression of idiotype and generation of suppressor T cells with idiotype-conjugated thymocytes. J Exp Med (1979) 1.56
The primary structure of bovine chromogranin A: a representative of a class of acidic secretory proteins common to a variety of peptidergic cells. EMBO J (1986) 1.52
K variant of butyrycholinesterase and late-onset Alzheimer's disease. Lancet (1998) 1.52
Antihypertensive and renal effects of captopril in relation to renin activity and bradykinin-induced vasodilation. Clin Pharmacol Ther (1982) 1.51
Reconstitution of a Mg-ATP-dependent protein phosphatase and its activation through a phosphorylation mechanism. FEBS Lett (1982) 1.51
Targeted gene knockout mediated by triple helix forming oligonucleotides. Nat Genet (1998) 1.51
Seasonal distribution of adenoviruses, enteroviruses and reoviruses in urban river water. Microbiol Immunol (1995) 1.51
Psychosis and aggression in Alzheimer's disease: the effect of dopamine receptor gene variation. J Neurol Neurosurg Psychiatry (2001) 1.50
Activation of endothelial L-arginine pathway in resistance arteries. Effect of age and hypertension. Hypertension (1990) 1.47
The gene for Darier's disease maps to chromosome 12q23-q24.1. Hum Mol Genet (1993) 1.47
The natural history of low grade non-Hodgkin's lymphoma and the impact of a no initial treatment policy on survival. Q J Med (1991) 1.45
Changes of immunoregulatory cells induced by psychological and physical stress: relationship to plasma catecholamines. Clin Exp Immunol (1984) 1.45
Factors affecting neonatal jaundice. Arch Dis Child (1979) 1.45
Drug and alcohol referrals: are elderly substance abuse diagnoses and referrals being missed? BMJ (1994) 1.41
Calcium channels in thrombin-activated human platelet membrane. Nature (1988) 1.39
[Insulin--a side issue or indeed the cause of hypertension?]. Dtsch Med Wochenschr (1991) 1.39
Reliable standards of care are determined by consensus of those who provide that care. J Manipulative Physiol Ther (1991) 1.39
Low-back pain. Factors of value in predicting outcome. Spine (Phila Pa 1976) (1990) 1.38
Failure of L-arginine to induce hypotension in patients with a history of accelerated-malignant hypertension. J Hum Hypertens (2000) 1.38
The influence of the operating surgeon's specialisation on patient survival in ovarian carcinoma. Br J Cancer (1994) 1.37
Interaction between endothelin-1 and endothelium-derived relaxing factor in human arteries and veins. Circ Res (1990) 1.37
Conditioned suppression as a sensitive baseline for social facilitation. J Exp Anal Behav (1969) 1.36
Semantic memory is impaired in both dementia with Lewy bodies and dementia of Alzheimer's type: a comparative neuropsychological study and literature review. J Neurol Neurosurg Psychiatry (2001) 1.36
Expression of tenascin by vascular smooth muscle cells. Alterations in hypertensive rats and stimulation by angiotensin II. Am J Pathol (1992) 1.36
Longitudinal study of prognostic factors in established periodontitis patients. J Clin Periodontol (1997) 1.36
Correlation of platelet calcium with blood pressure. Effect of antihypertensive therapy. N Engl J Med (1984) 1.34
Endothelin stimulates phospholipase C in cultured vascular smooth muscle cells. Biochem Biophys Res Commun (1988) 1.32
Leukemia inhibitory factor determines the growth status of injured adult sensory neurons. J Neurosci (2001) 1.30
Modification of surfaces with cell adhesion peptides alters extracellular matrix deposition. Biomaterials (1999) 1.28
Endothelium-derived contracting factors. Hypertension (1992) 1.27
Targeted correction of an episomal gene in mammalian cells by a short DNA fragment tethered to a triplex-forming oligonucleotide. J Biol Chem (1999) 1.27
Media coverage and public reaction to a celebrity cancer diagnosis. J Public Health (Oxf) (2010) 1.26
Genome-wide association with MRI atrophy measures as a quantitative trait locus for Alzheimer's disease. Mol Psychiatry (2010) 1.24
Unexpected sudden infant deaths in Gosport--some comparisons between service and civilian families. J R Nav Med Serv (1983) 1.23
Induction of growth-related metabolism in human vascular smooth muscle cells by low density lipoprotein. J Biol Chem (1989) 1.23
Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease. Nat Genet (1999) 1.22
Stretch affects phenotype and proliferation of vascular smooth muscle cells. Mol Cell Biochem (1995) 1.21
Soft-tissue hemangiomas in infants and children: diagnosis using Doppler sonography. AJR Am J Roentgenol (1998) 1.20
Payment to healthcare professionals for patient recruitment to trials: systematic review and qualitative study. Health Technol Assess (2008) 1.19
Endothelium-dependent responses in carotid and renal arteries of normotensive and hypertensive rats. Hypertension (1988) 1.19
BMP-induced osteogenesis on the surface of hydroxyapatite with geometrically feasible and nonfeasible structures: topology of osteogenesis. J Biomed Mater Res (1998) 1.19
Activation of phospholipase A2 by endothelin in cultured vascular smooth muscle cells. Biochem Biophys Res Commun (1989) 1.18
Sequelae of neonatal jaundice. Br Med J (1970) 1.18
Effect of trypsinization on the activity of human factor H. J Immunol (1982) 1.17
Activation of human peripheral monocytes by angiotensin II. FEBS Lett (1994) 1.16
A series of systematic reviews to inform a decision analysis for sampling and treating infected diabetic foot ulcers. Health Technol Assess (2006) 1.15
Importance of endothelium-derived nitric oxide in porcine coronary resistance arteries. Am J Physiol (1991) 1.15
Age-related decrease in cardiac and peripheral vascular responsiveness to isoprenaline: studies in normal subjects. Clin Sci (Lond) (1981) 1.14
Antihypertensive action of propranolol. Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertension. Am J Cardiol (1973) 1.13
5HT-kinetics and sensitivity of human blood platelets: variations with age, gender and platelet number. Thromb Haemost (1988) 1.13
Preparation of ribosome-free membranes from rat liver microsomes by means of lithium chloride. Biochem J (1969) 1.12
Interleukin-1 beta induces the production of an L-arginine-derived relaxing factor from cultured smooth muscle cells from rat aorta. Biochem Biophys Res Commun (1991) 1.11
A rat chamber and electrode procedure for avoidance conditioning. J Exp Anal Behav (1967) 1.11
Surgical workload and outcome after resection for carcinoma of the oesophagus and cardia. Br J Surg (2002) 1.11
The place of the calcium antagonist verapamil in antihypertensive therapy. J Cardiovasc Pharmacol (1982) 1.11
In vitro bone formation by rat marrow cell culture. J Biomed Mater Res (1996) 1.10
Pemphigoid gestationis: early onset and blister formation are associated with adverse pregnancy outcomes. Br J Dermatol (2009) 1.10
Processing of amyloid precursor protein in human primary neuron and astrocyte cultures. J Neurochem (1997) 1.10
Malignant melanoma of the vulva: a clinicopathological study of 50 women. Br J Obstet Gynaecol (1990) 1.10
Preclinical development of CAT-354, an IL-13 neutralizing antibody, for the treatment of severe uncontrolled asthma. Br J Pharmacol (2012) 1.10
Standardised consent forms on the website of the British Orthopaedic Association. J Bone Joint Surg Br (2008) 1.09
Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 in clinically healthy smokers. Circulation (1994) 1.08
Inhibition of cytokine-induced nitric oxide production by transforming growth factor-beta 1 in human smooth muscle cells. J Physiol (1992) 1.08